The leading cause of maternal deaths worldwide is postpartum hemorrhage (PPH). According to the World Health Organization, 14 million women experience PPH each year, resulting in 70,000 maternal deaths around the world annually. These maternal deaths are inequitably distributed globally and the burden is largely borne by those who live in low- and middle-income countries (LMIC). A majority of these deaths are preventable. Adequate and timely interventions, including uterotonics (drugs which induce uterine contraction) are the gold standard for the prevention and treatment of PPH. In low- and middle-income countries these drugs are often not available because of cost, supply chain and systematic barriers. In the absence of uterotonics, timely surgery consisting of a trio of surgical procedures is necessary to stop the bleeding and save the patient. This highlights the need for training tools for surgeons.
